Literature DB >> 15075002

Epidemiologic analysis of the Tehran Cancer Institute Data System Registry (TCIDSR).

B Larijani1, M Shirzad, M A Mohagheghi, V Haghpanah, A R Mosavi-Jarrahi, S M Tavangar, A R Vassigh, A Hossein-Nezhad, F Bandarian, R Baradar-Jalili.   

Abstract

OBJECTIVE: To review epidemiological data on thyroid cancer in Iran.
METHODS: The Tehran Cancer Institute Data System Registry (TCIDSR) was used to identify patients with different histological types of thyroid cancer (TC) in Iran. Data were analysed from 438 thyroid cancer cases identified by the TCIDSR in 1998-99. Disease prevalence was calculated with reference to age, time and place.
RESULTS: The TCIDSR recorded 438 primary malignancies of the thyroid gland: papillary, follicular, medullary, and anaplastic carcinomas accounted for 67.1%, 10.7%, 5.3% and 4.3% of cases, respectively. The remaining 12.6% were classified as OD (other diagnoses). The prevalence of TC was highest in ethnic Farsis. The age range of patients was 8-85 years. Mean patient age was 44.52+17.03 years (mean + SD) overall, 47.74+18.10 years in female patients and 43.04+16.34 years in male patients. Anaplastic (6.5% vs. 3.3%) and medullary (10.0% vs. 3.0%) cancers were more common in men than women.
CONCLUSION: This study was undertaken to define the epidemiological aspects of thyroid carcinoma in Iran, an area of endemic iodine deficiency until fairly recently. Against expectation for an iodine-deficient area, the frequency distribution of tumours in our study was closer to that seen in iodine-rich areas. Additional research on the risk factors for thyroid cancer--genetic, ethnic, geographic and environmental--is needed to explain the high incidence of PTC overall, and among ethnic Farsis in particular, in Iran.

Entities:  

Mesh:

Year:  2004        PMID: 15075002

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  17 in total

1.  Undifferentiated (anaplastic) thyroid carcinoma and iodine intake in Salta, Argentina.

Authors:  H R Harach; Macarena Galíndez; Mónica Campero; G A Ceballos
Journal:  Endocr Pathol       Date:  2013-09       Impact factor: 3.943

2.  Inequalities in cancer distribution in tehran; a disaggregated estimation of 2007 incidencea by 22 districts.

Authors:  Marzieh Rohani Rasaf; Rashid Ramezani; Mitra Mehrazma; Mohamad Reza Rohani Rasaf; Mohsen Asadi-Lari
Journal:  Int J Prev Med       Date:  2012-07

3.  Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer.

Authors:  Fatemeh Khatami; Bagher Larijani; Ramin Heshmat; Abbasali Keshtkar; Mahsa Mohammadamoli; Ladan Teimoori-Toolabi; Shirzad Nasiri; Seyed Mohammad Tavangar
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

4.  Genetic and Epigenetic of Medullary Thyroid Cancer

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Iran Biomed J       Date:  2017-11-11

5.  Circulating Tumor BRAF Mutation and Personalized Thyroidzzm321990Cancer Treatment

Authors:  Fatemeh Khatami; Bagher Larijani; Seyed Mohammad Tavangar
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

Review 6.  Current Diagnostic Status of Pheochromocytomaand Future Perspective: A Mini Review.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Iran J Pathol       Date:  2017-07-01

Review 7.  Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  J Diabetes Metab Disord       Date:  2018-03-26

Review 8.  Oncometabolites as biomarkers in thyroid cancer: a systematic review.

Authors:  Fatemeh Khatami; Moloud Payab; Masoumeh Sarvari; Kambiz Gilany; Bagher Larijani; Babak Arjmand; Seyed Mohammad Tavangar
Journal:  Cancer Manag Res       Date:  2019-02-25       Impact factor: 3.989

9.  Exploring Spatial Patterns of Colorectal Cancer in Tehran City, Iran

Authors:  Kamyar Mansori; Alireza Mosavi-Jarrahi; Ali Ganbary Motlagh; Masoud Solaymani-Dodaran; Masoud Salehi; Alireza Delavari; Ali Sanjari Moghaddam; Mohsen Asadi-Lari
Journal:  Asian Pac J Cancer Prev       Date:  2018-04-27

Review 10.  Multiple Endocrine Neoplasia Syndromes from Genetic and Epigenetic Perspectives.

Authors:  Fatemeh Khatami; Seyed Mohammad Tavangar
Journal:  Biomark Insights       Date:  2018-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.